CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CTMX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $555.64M
- EPS (TTM)
- -$0.51
- Dividend yield
- None
- 52-week range
- 2.48 – 8.21
- Day range
- 2.52 – 2.65
- Volume / Avg
- 2.34M / 3.35M
- Beta
- —
- Shares outstanding
- 217.90M
- Next earnings
- Nov 5, 2026
52-week range
CTMX stock today
On Oct 7, CTMX ended the session at $2.55, shedding $0.01 (0.39%), versus the S&P 500's 0.22% decline. At this level, CTMX sits near the bottom of its 52-week range of $2.48 to $8.21: 68.9% below the high, set on Mar 16, 2026 and 2.8% above the low. CTMX is down 40.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 23.4%.
CytomX Therapeutics has posted a net loss over the last twelve months (EPS of -$0.51), so its P/E ratio is not meaningful. CytomX Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About CytomX Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.09
CytomX Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MNPRMonopar Therapeutics Inc. | 83.78 | +5.29% | $562.35M | vs CTMX |
| PHATPhathom Pharmaceuticals Inc. | 6.81 | +0.44% | $550.94M | vs CTMX |
| CRMDCorMedix Inc. | 7.28 | 0.00% | $567.43M | vs CTMX |
| STTKShattuck Labs Inc. | 5.66 | -3.50% | $567.55M | vs CTMX |
| EVOEvotec SE ADR | 1.61 | -1.23% | $572.18M | vs CTMX |
| AQSTAquestive Therapeutics Inc. | 4.62 | +0.22% | $579.86M | vs CTMX |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs CTMX |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs CTMX |
Indexes, lists and sector
CytomX Therapeutics stock FAQ
What is CytomX Therapeutics's stock price today?
CTMX last traded at $2.55 as of Oct 7, 4:00 PM EDT, down 0.39% on the day. Prices are delayed at least 15 minutes.
When is CytomX Therapeutics's next earnings date?
CytomX Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.09.
What is the CTMX 52-week high?
The 52-week high for CTMX is $8.21 and the 52-week low is $2.48. The stock is currently 68.9% below its high.